Reinventing Biotech’s Business Model: The Photo Gallery

4/4/12Follow @ldtimmerman

(Page 5 of 24)

NEXT IMAGE >>
Reinventing Biotech’s Business Model — Brian Atwood, the co-founder and managing director at Versant Ventures, shared his experience in helping craft Inception Sciences as a new drug development model hopefully will generate investment returns, and give Big Pharma companies the kind of drug candidates they need.
Photo by Luke Timmerman

Luke Timmerman is the National Biotech Editor of Xconomy. E-mail him at ltimmerman@xconomy.com Follow @ldtimmerman

Currently on Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 previous page
  • R. Jones

    When you talk about having enough former company T-shirts to build a quilt, you are really talking about enough soul crushing layoffs to kill ones desire to continue pursuing a career in this industry. We’re talking about a huge quilt that represents the loss of billions of dollars.

  • R. Jones

    Quip: a witty or funny observation or response usually made on the spur of the moment.

  • Pingback: Virtual Biotech Companies: Built on Solid Bedrock or Unstable Landfill? | Xconomy